Publication, Part of Health and Care of People with Learning Disabilities

Health and Care of People with Learning Disabilities, Experimental Statistics 2023 to 2024

Experimental statistics, Other reports and statistics, Official statistics in development

Publication Date:: 12 Dec 2024
Geographic Coverage:: England
Geographical Granularity:: Regions, Sub-Integrated Care Boards
Date Range:: 01 Apr 2023 to 31 Mar 2024

Current Chapter

View all

Next Chapter

Calculation Methodologies and Suppression

Summary

The aim of this publication is to provide information about the key differences in healthcare between people with a learning disability and those without. It contains aggregated data on key health issues for people who are recorded by their GP as having a learning disability, and comparative data about a control group who are not recorded by their GP as having a learning disability.

Eight new indicators were introduced in the 2023-24 reporting year for patients with and without a recorded learning disability. These relate to:

• Patients treated with melatonin

• Gender breakdown for attention deficit hyperactivity disorder (ADHD)

• Anxiety prevalence

Six indicators have been removed from the 2023-24 reporting year relating to:

• Kidney disease

• Epilepsy

• Seizure frequency

More information on these changes can be found in the Data Quality section of this publication. Data has been collected from participating practices using EMIS and Cegedim Healthcare Systems GP systems.

Highlights

England, 2023-24

Below are the key facts from the publication. Please note that all comparisons are statistically significantly different unless stated otherwise.

Key Facts

Coverage

54.7% of patients registered in England in 2023-24 were included in this publication, compared with 55.1% of patients in 2022-23.

Learning disability prevalence

0.5% of the patients included in this publication were recorded by their GP as having a learning disability in 2023-24.

Autism prevalence

The percentage of patients who have a learning disability and an autism diagnosis has increased each year from 21.4% in 2017-18 to 32.4% in 2022-23 and 33.3% in 2023-24.

The percentage of patients without a learning disability who have a diagnosis of autism has increased from 0.5% in 2017-18 to 1.0% in 2022-23 and 1.2% in 2023-24.

Health checks

79.6% of patients with a learning disability had a Learning Disability Health Check in 2023-24. This is not statistically significantly different to 2022-23 (79.8%) but an increase when compared to 2021-22 (71.8%).

Learning disability and ADHD prevalence

The percentage of patients who have a learning disability and an ADHD diagnosis has increased each year from 5.5% in 2017-18 to 8.6% in 2022-23 and 9.0% in 2023-24.

The percentage of female patients who have a learning disability and an ADHD diagnosis is 5.3% for 2023-24 and is lower than for male patients (11.4%).

The percentage of patients without a learning disability who have a diagnosis of ADHD has increased from 0.5% in 2017-18 to 1.0% in 2022-23 and 1.2% in 2023-24.

The highest rates of ADHD are in those who are autistic. Amongst those who are autistic but with no learning disability, 19.8% had an ADHD diagnosis in 2023-24. 17.1% of those who are autistic and had a learning disability also had a diagnosis of ADHD.

Prescribing - antipsychotics

The percentage of patients with a learning disability who were prescribed antipsychotics has decreased from 14.4% in 2022-23 to 13.9% in 2023-24.

The percentage of patients without a learning disability who were prescribed antipsychotics has remained stable at 0.9% over the same period.

Prescribing - antidepressants

The percentage of patients with a learning disability who were prescribed antidepressants has increased each year from 20.8% in 2020-21 to 21.7% in 2022-23 and 22.1% in 2023-24.

The percentage of patients without a learning disability diagnosis and treated with antidepressants was 10.9% in 2023-24.

Learning disability and Down syndrome prevalence

The percentage of patients with a learning disability and a Down syndrome diagnosis has decreased each year from 13.9% in 2017-18 to 11.0% in 2022-23 and 10.6% in 2023-24.

Melatonin

The percentage of registered patients under twenty-five with a learning disability who were treated with melatonin was 12.8% in 2023-24.

The percentage of patients under twenty-five without a learning disability who were treated with melatonin was lower at 0.7%

Anxiety

The percentage of registered patients with a learning disability who have a diagnosis of anxiety was 9.9% in 2023-24.

The percentage of patients without a learning disability who have a diagnosis of anxiety was lower at 5.1%.

The highest rates of anxiety were in those who were autistic. 12.8% of those who had a learning disability and were autistic also had a diagnosis of anxiety. 12.0% of those who were autistic but without a learning disability had a diagnosis of anxiety.

Interactive Tool Notice

The Interactive Tool is currently unavailable due to a technical issue which we are working to resolve. NHS England apologises for any inconvenience caused and will provide an update to users as soon as possible.